Bristol-Myers Squibb (NYSE: BMY) last traded at $67.01, up 2.35% on the session. The quote above updates while this page is open; the figures below are drawn from Bristol-Myers Squibb’s own filings and are restated only when a new one is published.
Bristol-Myers Squibb trades on NYSE under the ticker BMY. It is classified in the Healthcare sector, Pharmaceuticals industry. Its market capitalisation is $136.88 billion.
Healthcare sectorPharmaceuticalsListed on NYSE
Valuation measures for Bristol-Myers Squibb, derived from the latest quote and its most recent SEC filing.
| Market cap | $136.88B |
|---|---|
| Enterprise value | $193.48B |
| P/E ratio | 14.73 |
| Price / sales | 2.78 |
| Price / book | 6.13 |
| Beta | 0.24 |
Trailing-twelve-month figures tagged in Bristol-Myers Squibb's XBRL filings with the SEC.
| Revenue (TTM) | $49.19B |
|---|---|
| Net income (TTM) | $9.28B |
| EPS (TTM) | $4.55 |
| Return on equity | 41.59% |
| Cash | $8.72B |
Range and volume for BMY over the past 52 weeks.
| 52-week high | $68.64 |
|---|---|
| 52-week low | $42.52 |
| Volume | 6.83M |
| Average volume | 12.36M |
| Previous close | $65.47 |
Dividend history for Bristol-Myers Squibb over the trailing twelve months.
| Dividend yield | 3.75% |
|---|---|
| Dividend per share (TTM) | $2.51 |
| Payout ratio | 55.16% |
Other Healthcare companies tracked on FurlPay Markets.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.